By expenditures
| Name | Title | Type |
|---|---|---|
| Scott Peck | SHAREHOLDER | Auditee |
| Kelley Riddle | Vice President of Business Affairs | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 293430 | 2023 | 2024-03-04 | Mp Group INC | $25.69M |
| 36169 | 2022 | 2023-01-02 | Mp Group INC | $20.73M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 293430 | 2023 | 2024-03-04 | 948574 | 2023-003 | Significant Deficiency | - | N |
| 293430 | 2023 | 2024-03-04 | 948573 | 2023-002 | Significant Deficiency | - | N |
| 293430 | 2023 | 2024-03-04 | 372132 | 2023-003 | Significant Deficiency | - | N |
| 293430 | 2023 | 2024-03-04 | 372131 | 2023-002 | Significant Deficiency | - | N |
| 36169 | 2022 | 2023-01-02 | 608413 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608412 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608411 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608410 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608409 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608408 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608407 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608406 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608405 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608404 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608403 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608402 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608401 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608400 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608399 | 2022-003 | Significant Deficiency | - | L |
| 36169 | 2022 | 2023-01-02 | 608398 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608397 | 2022-003 | Significant Deficiency | - | L |
| 36169 | 2022 | 2023-01-02 | 608396 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 608395 | 2022-003 | Significant Deficiency | - | L |
| 36169 | 2022 | 2023-01-02 | 608394 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31971 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31970 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31969 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31968 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31967 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31966 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31965 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31964 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31963 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31962 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31961 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31960 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31959 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31958 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31957 | 2022-003 | Significant Deficiency | - | L |
| 36169 | 2022 | 2023-01-02 | 31956 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31955 | 2022-003 | Significant Deficiency | - | L |
| 36169 | 2022 | 2023-01-02 | 31954 | 2022-002 | Significant Deficiency | - | I |
| 36169 | 2022 | 2023-01-02 | 31953 | 2022-003 | Significant Deficiency | - | L |
| 36169 | 2022 | 2023-01-02 | 31952 | 2022-002 | Significant Deficiency | - | I |